OMX Nordic 40
2.298,23
PKT
-11,77
PKT
-0,51
%
Werbung
Analysen zu OMX Nordic 40-Werten
Datum | Rating | Analyst | |
---|---|---|---|
29.01.25 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
28.01.25 | Nokia Overweight | JP Morgan Chase & Co. | |
28.01.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
28.01.25 | Novo Nordisk Buy | UBS AG | |
27.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
27.01.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
27.01.25 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
24.01.25 | Novo Nordisk Buy | UBS AG | |
24.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
24.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
24.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Underweight | Barclays Capital | |
24.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
24.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Sell | Goldman Sachs Group Inc. | |
24.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
24.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Sell | UBS AG | |
24.01.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
23.01.25 | Volvo (B) Neutral | UBS AG | |
22.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
21.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
21.01.25 | Novo Nordisk Buy | UBS AG | |
20.01.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
20.01.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
17.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
17.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
17.01.25 | Novo Nordisk Buy | UBS AG | |
17.01.25 | Volvo (B) Buy | Jefferies & Company Inc. | |
16.01.25 | Volvo (B) Neutral | UBS AG | |
16.01.25 | Novo Nordisk Buy | UBS AG | |
16.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Sell | Goldman Sachs Group Inc. | |
16.01.25 | Nokia Sell | Goldman Sachs Group Inc. | |
15.01.25 | Volvo (B) Buy | Jefferies & Company Inc. | |
15.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
15.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
14.01.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
13.01.25 | Novo Nordisk Buy | UBS AG | |
13.01.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
13.01.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
13.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
12.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Underperform | Bernstein Research | |
12.01.25 | Nokia Market-Perform | Bernstein Research |